Skip to Content

Frequently Searched

Supported by

Perspectives: Published Editorials and Industry Updates

Welcome to Perspectives, our blog designed to keep members, oncology stakeholders, and anyone interested in enhancing the care experience for oncology patients informed on critical issues. You’ll hear from thought leaders and learn about the impact and benefits of medically integrated pharmacy, operational insights designed to support you in the day-to-day delivery of care, as well as timely industry issues facing oncology pharmacy professionals.

SORT

NCODA AT 10 

April 22, 2025
This article is about the founding and evolution of NCODA, sparked by the growing need for better oral oncolytic care, and how the organization has continued to adapt, innovate, and stay true to its patient-centered, collaborative mission over the past decade.

OncolyticsToday: Measuring the Economic Value of Pharmacogenomics in Oncology

April 22, 2025
This article highlights the economic potential of pharmacogenomics (PGx) in precision medicine, particularly in oncology, by demonstrating its ability to improve patient outcomes and reduce costs. It emphasizes the need for more cost-effectiveness studies to support PGx adoption and the benefits of preemptive PGx testing to enhance clinical decision-making and minimize adverse drug reactions.

NCODA Announces Brand Updates, a New Website, and a Future of Innovation and Collaboration 

April 13, 2025
As an organization, NCODA has always been committed to supporting our members in advancing the medically integrated healthcare team and advancing patient care. Today, we are excited to share some important changes that strengthen that commitment and reflect our evolution and focus. We have grown tremendously and are introducing meaningful updates to our brand and our online presence at ncoda.org.  

Caring for Patients in Every Step of their Journey 

March 31, 2025
NCODA recently sat down with members of the pharmacy team at Hematology-Oncology Associates of Central New York (HOACNY) to discuss the advantages of a medically integrated practice in their experience.

High Tech, High Touch: The MIP Model at Texas Oncology 

March 31, 2025
As we look at the implementation and value of the medially integrated pharmacy (MIP) model and how members are making a difference in the future of oncology care, we recently spoke with Texas Oncology leaders Gury Doshi, MD, hematology and medical oncologist, and Neal Dave, PharmD, executive director of pharmacy operations, for their perspectives.

Accreditation Advantage or Burden?

March 28, 2025
This article explores the challenges of traditional accreditation and how NCODA’s Center of Excellence program offers a practical, patient-centered solution for oncology practices and partners.

Enhanced Clarity for Bispecific Therapies: A Call to Action

February 12, 2025
NCODA supports the NCCN’s push for clearer terminology in bispecific antibody therapies—like the use of “lymphocyte engagers”—to improve safety, streamline care, and guide oncology practices in managing unique adverse events.